TY - JOUR
T1 - Adipose-tissue-derived therapeutic cells in their natural environment as an autologous cell therapy strategy
T2 - the microtissue-stromal vascular fraction
AU - Nürnberger, S.
AU - Lindner, C.
AU - Maier, J.
AU - Strohmeier, K.
AU - Wurzer, C.
AU - Slezak, P.
AU - Suessner, S.
AU - Holnthoner, W.
AU - Redl, H.
AU - Wolbank, S.
AU - Priglinger, E.
N1 - Funding Information:
We would like to acknowledge Dr Hajnal Kiprov and Dr Matthias Sandhofer for providing liposuction material and valuable discussion. This work was funded by a grant from the Austrian Research Promotion Agency (FFG) (Bridge1 programme, grant number 846062).
Publisher Copyright:
© 2019, AO Research Institute Davos. All rights reserved.
PY - 2019/2/22
Y1 - 2019/2/22
N2 - The prerequisite for a successful clinical use of autologous adipose-tissue-derived cells is the highest possible regenerative potential of the applied cell population, the stromal vascular fraction (SVF). Current isolation methods depend on high enzyme concentration, lysis buffer, long incubation steps and mechanical stress, resulting in single cell dissociation. The aim of the study was to limit cell manipulation and obtain a derivative comprising therapeutic cells (microtissue-SVF) without dissociation from their natural extracellular matrix, by employing a gentle good manufacturing practice (GMP)-grade isolation. The microtissue-SVF yielded larger numbers of viable cells as compared to the improved standard-SVF, both with low enzyme concentration and minimal dead cell content. It comprised stromal tissue compounds (collagen, glycosaminoglycans, fibroblasts), capillaries and vessel structures (CD31+, smooth muscle actin+). A broad range of cell types was identified by surface-marker characterisation, including mesenchymal, haematopoietic, pericytic, blood and lymphatic vascular and epithelial cells. Subpopulations such as supra-adventitial adipose-derived stromal/stem cells and endothelial progenitor cells were significantly more abundant in the microtissue-SVF, corroborated by significantly higher potency for angiogenic tube-like structure formation in vitro. The microtissue-SVF showed the characteristic phenotype and tri-lineage mesenchymal differentiation potential in vitro and an immunomodulatory and pro-angiogenic secretome. In vivo implantation of the microtissue-SVF combined with fat demonstrated successful graft integration in nude mice. The present study demonstrated a fast and gentle isolation by minor manipulation of liposuction material, achieving a therapeutically relevant cell population with high vascularisation potential and immunomodulatory properties still embedded in a fraction of its original matrix.
AB - The prerequisite for a successful clinical use of autologous adipose-tissue-derived cells is the highest possible regenerative potential of the applied cell population, the stromal vascular fraction (SVF). Current isolation methods depend on high enzyme concentration, lysis buffer, long incubation steps and mechanical stress, resulting in single cell dissociation. The aim of the study was to limit cell manipulation and obtain a derivative comprising therapeutic cells (microtissue-SVF) without dissociation from their natural extracellular matrix, by employing a gentle good manufacturing practice (GMP)-grade isolation. The microtissue-SVF yielded larger numbers of viable cells as compared to the improved standard-SVF, both with low enzyme concentration and minimal dead cell content. It comprised stromal tissue compounds (collagen, glycosaminoglycans, fibroblasts), capillaries and vessel structures (CD31+, smooth muscle actin+). A broad range of cell types was identified by surface-marker characterisation, including mesenchymal, haematopoietic, pericytic, blood and lymphatic vascular and epithelial cells. Subpopulations such as supra-adventitial adipose-derived stromal/stem cells and endothelial progenitor cells were significantly more abundant in the microtissue-SVF, corroborated by significantly higher potency for angiogenic tube-like structure formation in vitro. The microtissue-SVF showed the characteristic phenotype and tri-lineage mesenchymal differentiation potential in vitro and an immunomodulatory and pro-angiogenic secretome. In vivo implantation of the microtissue-SVF combined with fat demonstrated successful graft integration in nude mice. The present study demonstrated a fast and gentle isolation by minor manipulation of liposuction material, achieving a therapeutically relevant cell population with high vascularisation potential and immunomodulatory properties still embedded in a fraction of its original matrix.
KW - Adipose Tissue/cytology
KW - Adult
KW - Biomarkers/metabolism
KW - Cell Differentiation
KW - Cell Lineage
KW - Cell Shape
KW - Cell Survival
KW - Cell- and Tissue-Based Therapy
KW - Extracellular Matrix/metabolism
KW - Humans
KW - Neovascularization, Physiologic
KW - Stromal Cells/cytology
KW - Transplantation, Autologous
KW - Stromal vascular fraction
KW - Adipose-derived stromal/stem cells
KW - Angiogenesis
KW - Endothelial progenitor cells
KW - Extracellular matrix
UR - http://www.scopus.com/inward/record.url?scp=85061990571&partnerID=8YFLogxK
U2 - 10.22203/eCM.v037a08
DO - 10.22203/eCM.v037a08
M3 - Article
C2 - 30793275
AN - SCOPUS:85061990571
SN - 1473-2262
VL - 37
SP - 113
EP - 133
JO - European cells & materials
JF - European cells & materials
ER -